DC3 Therapeutics LLC

Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information

Walking Fish Therapeutics, Inc. is a biotech company based in South San Francisco, CA, specializing in the development of cell-based therapeutics for the treatment of serious diseases, with a focus on oncology and regenerative therapies. They have created a powerful B cell platform that harnesses the production capabilities of B cells to deliver multiple potent therapeutic proteins, offering potential applications in various fields such as autoimmune diseases, infectious diseases, deficiency diseases, and cancer treatment. Co-founded and led by Lewis Rusty Williams, an experienced entrepreneur in the biotech industry, Walking Fish Therapeutics has assembled a distinguished team of experts in cell engineering, manufacturing, and clinical research, supported by renowned scientific and strategic advisors. With their deep understanding of B cell biology and critical advances in engineering technologies, Walking Fish is at the forefront of this emerging field, aiming to revolutionize the development of B cell therapies for multiple diseases.Generated from the website